IN8bio, Inc. beat EPS estimates 67% of the time across 3 reported quarters (2 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.61 | $-0.25 | +59.0% | Beat |
| Q12026 FY2026 | $-0.59 | $-0.26 | +55.9% | Beat |
| Q42025 FY2025 | $-0.18 | $-0.26 | -44.4% | Miss |
Back to INAB overview · INAB holders · INAB KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.